SCHEMBL2820205

SCHEMBL2820205

Cc1nc(CC2CCCC2)cs1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
GAA P10253 1/20 0.40
PDE10A Q9Y233 1/20 0.40
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
SLC6A3 Q01959 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HCRTR2 O43614 1/20 0.36
DRD2 P14416 1/20 0.36
HTR6 P50406 1/20 0.36
PKM P14618 1/20 0.36
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
LMNA P02545 1/20 0.35
FABP6 P51161 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9103382 0.83 HRH3 (0.42) CNR1CNR2GAAPDE10AMEN1
SCHEMBL31200058 0.80 SMN1; SMN2 (0.35) GAAPDE10AMEN1KMT2ASLC6A3
SCHEMBL31200380 0.79 SMN1; SMN2 (0.40) GAAMEN1KMT2ASLC6A3SMN1; SMN2
SCHEMBL2819181 0.79 CNR1 (0.39) CNR1CNR2GAASLC6A3SMN1; SMN2
SCHEMBL28160951 0.78 HTR6 (0.39) CNR1CNR2SMN1; SMN2RAB9ADRD2
SCHEMBL28161480 0.78 CNR1 (0.38) CNR1CNR2SMN1; SMN2RAB9ADRD2
SCHEMBL2819208 0.77 DRD2 (0.45) CNR1CNR2MEN1KMT2ASLC6A3
SCHEMBL15549396 0.76 LMNA (0.46) CNR1CNR2GAASMN1; SMN2NPC1
SCHEMBL31200393 0.76 NPC1 (0.43) GAAMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL17709923 0.76 HTR6 (0.34) CNR1CNR2NPC1DRD2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240890-A1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same DONG WHA PHARMACEUTICAL IND. CO., LTD. 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240890-A1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same CMA1, IL5, HRH4 CNR1 1692/4885CNR2 1305/4885GAA 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.